Pharmaceutical Companies RNA Vaccine 
The Pharma Data
JANUARY 21, 2021
21, 2021 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. In the ATLAS study, CABENUVA met the primary endpoint for noninferiority (the proportion of participants with plasma HIV-1 RNA ?50 Two percent of patients in both treatment arms had an HIV-1 RNA count ?50
Broad Institute
MAY 14, 2024
William Studier for development of widely used protein- and RNA-production platform By Corie Lok May 14, 2024 Breadcrumb Home Merkin Prize in Biomedical Technology awarded to F. Merkin Prize in Biomedical Technology for his development of an efficient, scalable method of producing RNA and proteins in the laboratory.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
MARCH 4, 2021
Takeda Pharmaceutical Company Limited ( TSE:4502/NYSE:TAK ) (“Takeda”) and Ovid Therapeutics Inc. About Takeda Pharmaceutical Company Limited. We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. For more information on Ovid, please visit www.ovidrx.com. .
Codon
MARCH 24, 2024
Water accounts for 70 percent of a bacterium by mass; the other 30 percent includes everything else: proteins, RNA, DNA, lipids, and so on. MenAfriVac is a meningococcal vaccine that remains active, without refrigeration, for up to four days and has significantly boosted vaccine coverage in parts of sub-Saharan Africa.
The Pharma Data
OCTOBER 27, 2020
As part of those efforts, it has become increasingly clear that to tackle the pandemic at a global level the development of medicines that can prevent and treat the virus, in addition to the development of vaccines, will be crucial. The company has compounds in various stages of clinical and preclinical development with a focus on oncology.
DrugBank
NOVEMBER 25, 2024
Whether it's controlled-release capsules transforming chronic disease management or lipid nanoparticles enabling life-saving mRNA vaccines, these advancements have redefined therapeutic possibilities. Despite challenges like anti-PEG antibodies, its promise for creating long-lasting therapies continues to grow.
Codon
SEPTEMBER 29, 2024
But, regardless of which was first, they all operated with the same core data as their mechanism for understanding life: messenger RNA ( mRNA ). The single remaining pharmaceutical company was thus nationalized, data was collected, and the trained model deployed in full force. First, the models targeted the oceans.
Expert insights. Personalized for you.
52 
Let's personalize your content